Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

被引:58
作者
Figlioli, Gisella [1 ]
Landi, Stefano [1 ]
Romei, Cristina [2 ]
Elisei, Rossella [2 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Endocrinol, I-56124 Pisa, Italy
关键词
Medullary thyroid carcinoma; RET gene mutations; RET gene polymorphisms; Meta-analysis; ENDOCRINE NEOPLASIA TYPE-2; CODON; 918; MUTATION; GERMLINE-SEQUENCE VARIANTS; TYROSINE KINASE ACTIVATION; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; MEN; 2A; MULTIVARIATE-ANALYSIS; DISEASE PHENOTYPE; CLINICOPATHOLOGICAL FEATURES;
D O I
10.1016/j.mrrev.2012.09.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Medullary thyroid carcinoma (MTC) is an uncommon malignant tumor arising from the calcitonin-producing parafollicular cells (C cells) of thyroid. It accounts for 5-10% of all thyroid cancers, and it mostly occurs as a sporadic entity (sMTC), but a familial pattern (fMTC) is also possible. RET protooncogene germline mutations are crucial for the onset and the progression of fMTC, and the occurrence of single nucleotide polymorphisms could predispose to the sporadic form. In order to clarify the role of this gene in MTC, we carefully reviewed the PubMed database using appropriate terms. First, we summarized current knowledge of the germline RET mutations, mutation spectrum, and prevalence. We then performed a meta-analysis on the available case-control association studies for sMTC. Finally, we carried out in silico predictions of the best associated variants in the attempt to better define their role in the disease. To date, a total of 39 different RET germline mutations have been identified in fMTC families. The most affected codons are 609, 611, 618, 620 (exon 10) and 634 (exon 11), encoding for the extracellular cysteine-rich domain, and codons 768 (exon 13) and 804 (exon 14) of the intracellular tyrosine kinase domain. Six polymorphisms with at least three studies were included in the meta-analysis (A45A [rs1800858], G691S [rs1799939], L769L [rs1800861 I, S836S [rs1800862], S904S [rs1800863], and IVS1-126G>T [rs2565206]). The meta-analysis demonstrated a modest association of sMTC susceptibility with S836S and a strong association with the IVS1-126G>T polymorphism. Besides RET polymorphisms, we also investigated the role of a few other low-penetrance alleles of genes involved in the RET pathway or in xenobiotic metabolism, but none of these were confirmed. Thus, despite the well-known molecular basis of fMTC, the genetic variants of the sporadic form are still poorly understood, and functional analyses are needed to better understand the consequence of such RET variants and to improve our knowledge on the disease. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 106 条
[41]   Risk Profiles and Penetrance Estimations in Multiple Endocrine Neoplasia Type 2A Caused by Germline RET Mutations Located in Exon 10 [J].
Frank-Raue, Karin ;
Rybicki, Lisa A. ;
Erlic, Zoran ;
Schweizer, Heiko ;
Winter, Aurelia ;
Milos, Ioana ;
Toledo, Sergio P. A. ;
Toledo, Rodrigo A. ;
Tavares, Marcos R. ;
Alevizaki, Maria ;
Mian, Caterina ;
Siggelkow, Heide ;
Huefner, Michael ;
Wohllk, Nelson ;
Opocher, Giuseppe ;
Dvorakova, Sarka ;
Bendlova, Bela ;
Czetwertynska, Malgorzata ;
Skasko, Elzbieta ;
Barontini, Marta ;
Sanso, Gabriela ;
Vorlaender, Christian ;
Maia, Ana Luiza ;
Patocs, Attila ;
Links, Thera P. ;
de Groot, Jan Willem ;
Kerstens, Michiel N. ;
Valk, Gerlof D. ;
Miehle, Konstanze ;
Musholt, Thomas J. ;
Biarnes, Josefina ;
Damjanovic, Svetozar ;
Muresan, Mihaela ;
Wuester, Christian ;
Fassnacht, Martin ;
Peczkowska, Mariola ;
Fauth, Christine ;
Golcher, Henriette ;
Walter, Martin A. ;
Pichl, Josef ;
Raue, Friedhelm ;
Eng, Charis ;
Neumann, Hartmut P. H. .
HUMAN MUTATION, 2011, 32 (01) :51-58
[42]   Mutations of the ret protooncogene in German multiple endocrine neoplasia families: Relation between genotype and phenotype [J].
FrankRaue, K ;
Hoppner, W ;
Frilling, A ;
Kotzerke, J ;
Dralle, H ;
Haase, R ;
Mann, K ;
Seif, F ;
Kirchner, R ;
Rendl, J ;
Deckart, HF ;
Ritter, MM ;
Hampel, R ;
Klempa, J ;
Scholz, GH ;
Raue, F ;
Bogner, U ;
Brabant, G ;
Grussendorf, M ;
Hartenstein, CH ;
Heidemann, P ;
Hensen, J ;
Dorr, AG ;
Hohne, T ;
HornigFranz, I ;
Hufner, M ;
Kress, I ;
Langer, HJ ;
Lottermoser, K ;
Schweikert, HU ;
Kusterer, K ;
Menken, U ;
Mercier, J ;
Oelkers, W ;
Ziegler, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1780-1783
[43]   RET genotypes in sporadic medullary thyroid cancer:: studies in a large Italian series [J].
Fugazzola, Laura ;
Muzza, Marina ;
Mian, Caterina ;
Cordella, Daniela ;
Barollo, Susi ;
Alberti, Luisella ;
Cirello, Valentina ;
Dazzi, Davide ;
Girelli, Maria Elisa ;
Opocher, Giuseppe ;
Beck-Peccoz, Paolo ;
Persani, Luca .
CLINICAL ENDOCRINOLOGY, 2008, 69 (03) :418-425
[44]   MEDULLARY-THYROID CARCINOMA - CLINICOPATHOLOGICAL FEATURES AND LONG-TERM FOLLOW-UP OF 65 PATIENTS TREATED DURING 1946 THROUGH 1970 [J].
GHARIB, H ;
MCCONAHEY, WM ;
TIEGS, RD ;
BERGSTRALH, EJ ;
GOELLNER, JR ;
GRANT, CS ;
VANHEERDEN, JA ;
SIZEMORE, GW ;
HAY, ID .
MAYO CLINIC PROCEEDINGS, 1992, 67 (10) :934-940
[45]   Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation [J].
Gimm, O ;
Neuberg, DS ;
Marsh, DJ ;
Dahia, PLM ;
Cuong, HV ;
Raue, F ;
Hinze, R ;
Dralle, H ;
Eng, C .
ONCOGENE, 1999, 18 (06) :1369-1373
[46]   Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation [J].
Gimm, O ;
Marsh, DJ ;
Andrew, SD ;
Frilling, A ;
Dahia, PLM ;
Mulligan, LM ;
Zajac, JD ;
Robinson, BG ;
Eng, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) :3902-3904
[47]   Over-representation of a germline variant in the gene encoding RET co-receptor GFRα-1 but not GFRα-2 or GFRα-3 in cases with sporadic medullary thyroid carcinoma [J].
Gimm, O ;
Dziema, H ;
Brown, J ;
Cuong, HV ;
Hinze, R ;
Dralle, H ;
Mulligan, LM ;
Eng, C .
ONCOGENE, 2001, 20 (17) :2161-2170
[48]   Genetic testing in medullary thyroid carcinoma syndromes: Mutation types and clinical significance [J].
Heshmati, HM ;
Gharib, H ;
Khosla, S ;
AbuLebdeh, HS ;
Lindor, NM ;
Thibodeau, SN .
MAYO CLINIC PROCEEDINGS, 1997, 72 (05) :430-436
[49]   RET-Mediated Gene Expression Pattern is Affected by Isoform but Not Oncogenic Mutation [J].
Hickey, Jessica G. ;
Myers, Shirley M. ;
Tian, Xuefei ;
Zhu, Shu Jun ;
Shaw, Julie L. V. ;
Andrew, Scott D. ;
Richardson, Douglas S. ;
Brettschneider, Julia ;
Mulligan, Lois M. .
GENES CHROMOSOMES & CANCER, 2009, 48 (05) :429-440
[50]   RegRNA: an integrated web server for identifying regulatory RNA motifs and elements [J].
Huang, Hsi-Yuan ;
Chien, Chia-Hung ;
Jen, Kuan-Hua ;
Huang, Hsien-Da .
NUCLEIC ACIDS RESEARCH, 2006, 34 :W429-W434